myLaurel Secures $12 Million for Home-Based Healthcare
In a significant move reflecting the growing demand for home-based healthcare, myLaurel, a progressive healthcare company, has successfully raised $12 million in funding from prominent investors, including Deerfield Management and GV. This infusion of capital comes on the heels of remarkable growth that myLaurel achieved in the previous year, showcasing a dramatic increase in patient volume and overall revenue. This funding will play a crucial role in extending myLaurel's reach and enhancing its innovative Acute Care at Home program.
Investor Confidence Fuels Expansion Plans
The substantial investment from leading firms highlights growing confidence in myLaurel's business model. The partnership with reputable organizations like Deerfield Management and GV (Google Ventures) indicates that the healthcare community recognizes the efficacy of myLaurel's services. With this new funding, myLaurel is poised to expand its partnership with notable systems, particularly through its ongoing collaboration with Ochsner Health.
The focus will be on scaling the Acute Care at Home initiative, which has demonstrated significant clinical and financial success. Ochsner Health and myLaurel have jointly developed a model that sets a benchmark in delivering high-acuity care to patients in their own homes. This proactive approach not only enhances patient outcomes but also alleviates the pressures faced by traditional healthcare facilities.
Meeting the Rising Demand for Home-Based Care
As the population ages, the need for effective home-based healthcare solutions continues to grow. The healthcare system faces increasing challenges, such as a potential shortage of hospital beds, which experts anticipate could occur due to demographic shifts and evolving patient needs. myLaurel’s model is strategically designed to tackle these challenges by enabling hospitals to deliver comprehensive care to patients in their own environments, markedly enhancing care access while reducing the burden on hospital systems.
Juan Vallarino, CEO of myLaurel, expressed optimism about the road ahead, stating, "Our momentum reflects both the urgency of the need and the strength of our care model solution. Partnering with systems like Ochsner, we illustrate that high-quality home-based care can enrich patient experiences, reduce costs, and considerably increase hospital capacity."
Innovative Care Models and Positive Outcomes
The successful development of the Acute Care at Home model stems from a growing recognition that many patients can be effectively treated outside traditional hospital settings. In 2024, myLaurel and Ochsner Health’s collaboration underscored an emergent approach to healthcare that not only meets rising demands but also emphasizes patient-centered care. This partnership has consistently achieved exemplary results across various metrics, setting the stage for further innovation.
Moses Adubi, Principal at Deerfield, noted, "myLaurel is pioneering a scalable care model that confronts one of the most pressing issues in healthcare—delivering safe and effective care to complex patients in their homes. We are confident that myLaurel is well-positioned to spearhead a transformation in acute care delivery that provides substantial benefits across the healthcare spectrum."
A Bright Future for Home Healthcare
With the ongoing evolution of healthcare delivery towards home-based solutions, myLaurel stands at the forefront, balancing an improved patient experience with enhanced operational efficiency for hospitals. By focusing on partnerships with health systems and payers, myLaurel not only supports patients but also bolsters the entire healthcare ecosystem.
The outcomes achieved speak volumes: remarkable reductions in emergency department utilization and readmissions have positioned myLaurel as a critical partner in the healthcare landscape. As the organization continues to innovate and expand its offerings, myLaurel proves to be a valuable ally in navigating the complexities of modern healthcare.
About myLaurel
myLaurel operates on the belief that patients deserve care in the comfort of their homes. By providing tech-enabled on-demand acute and transitional care services, myLaurel assists frail, elderly, or medically complex individuals in avoiding unnecessary hospital admissions. They collaborate closely with health systems to enhance patient outcomes, minimize avoidable healthcare usage, and ensure the highest standards of care and safety.
Headquartered in New York, myLaurel integrates sophisticated technology, diagnostics, and therapies to maximize its impact, achieving lower emergency department utilization and fewer readmissions for partnered hospitals. Their commitment to delivering results is backed by a patient satisfaction rating of 96, demonstrating their effectiveness in meeting the healthcare needs of society.
Frequently Asked Questions
What is myLaurel's main service offering?
myLaurel specializes in providing home-based acute and transitional care for elderly or complex patients, aiming to reduce hospital admissions.
Who are myLaurel's key investors?
Investors include Deerfield Management, GV (Google Ventures), and other prominent organizations that support innovative healthcare solutions.
How does myLaurel’s model benefit healthcare providers?
The model helps healthcare providers reduce hospital pressures, enhance patient experiences, and improve care delivery for complex patients.
What impact does myLaurel have on patient outcomes?
myLaurel reports significant reductions in emergency department visits and readmission rates, contributing to improved overall patient health.
What are myLaurel's future plans for expansion?
With new funding, myLaurel plans to expand its partnerships and enhance its Acute Care at Home program for greater market reach and patient service.
